medigraphic.com
SPANISH

Revista Cubana de Investigaciones Biomédicas

ISSN 1561-3011 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 1

<< Back

Rev Cubana Invest Bioméd 2014; 33 (1)

In utero programming: a challenge

Rodríguez VN, Martínez PTP, Martínez GR, Garriga RM, Fernández-Britto JE, Martínez FG
Full text How to cite this article

Language: Spanish
References: 19
Page: 94-101
PDF size: 93.40 Kb.


Key words:

In utero programming.

ABSTRACT

Introduction: recent epidemiological studies of different populations have shown that pre- and postnatal nutrition may influence adult susceptibility to suffer from glucose intolerance, hypertension, coronary heart disease and obesity. The theory that fetal environmental factors and in particular maternal nutrition exert an influence upon the susceptibility to suffer from certain conditions in adulthood, has achieved great support, especially because the topic has gradually gained space in molecular biology. The biochemical changes occurring during the intrauterine and prenatal stages of life involve a continuous supply by the mother of plastic and energy substrates, as well as their integration. Poor maternal nutrition, a deficient environment, and bad conditions at birth and during childhood, may result in the risk to suffer from atherosclerosis in adulthood.
Methods: Based on knowledge about in utero programming obtained from an exhaustive review, data about atherosclerotic risk factors drawn from research previously conducted, and information acquired about the topic.
Development: The relationship described between body measurements at birth and coronary heart disease was irrespective of gestational age in the various studies conducted in Sheffield. This problem may be confirmed not only by maternal malnutrition, but other well-known factors as well, cause low weight at birth. Alongside the mother's nutritional status, other pregnancy-related factors should also be considered, such as multiple births, chromosomal anomalies, congenital malformations, maternal age, parity and others.
Conclusions: In utero macro- and microdetermining factors during pregnancy cause atherosclerotic risk factors not only in adulthood, but since school age. Body measurement at birth is not determining if no injury occurs during the embryogenetic and fetal stages and during childhood.


REFERENCES

  1. Kermack W, McKendrick A, McKinlay P. Death-rates in Great Britain and Sweden. Lancet. 1934;698-703.

  2. Forsdahl A. Are poor living conditions in childhood and adolescence an important risk factor for arteriosclerotic heart disease? Br J Prev Soc Med. 1977;31: 91-5.

  3. Koupilova I, Leon DA. Birthweight and mortality from ischaemic heart disease and stroke in Swedish men aged 50-74 years. J Epidemiol Com Health. 1996;50:592 (abstract).

  4. Fall CHD, Vijayakumar M, Barker DJP, Osmond C, Duggleby S. Weight in infancy and prevalence of coronary heart disease in adult life. BMJ. 1995;310:17-19.

  5. Rodríguez Vargas N, Martínez Pérez TP, Martínez García R, Garriga Reyes M, Ortega Soto M. Hipertensión arterial en el escolar con antecedente de macrosomía o alto peso al nacer. Rev Cubana Invest Bioméd [revista en la Internet]. 2009 Jun [citado 2013 ene 16];28(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 03002009000200005&lng=es

  6. Rodríguez Vargas N, Martínez Pérez TP, Martínez García R, Garriga Reyes M, Ortega Soto M. Obesidad en el escolar con antecedente de macrosomía o alto peso al nacer. Rev Cubana Invest Bioméd [revista en la Internet]. 2009 Jun [citado 2013 ene 04];28(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 03002009000200009&lng=es

  7. Lucas. A, Fewtrell MS, Cole TJ. Fetal origins of adult diseases. The hypothesis revisited. BMJ. 1999;319:245-9.

  8. Barker DJP, Meade TW, Fall CHD, Lee A, Osmond C, Phipps K, Stirling Y. Relation of fetal and infant growth to plasma fibrinogen and Factor VII concentrations in adult life. BMJ. 1992;304:149-52.

  9. Barker DJP, Osmond C. Infant mortality, childhood, nutrition and ischaemic heart disease in England and Wales. Lancet. 1986;L1077-81.

  10. Barker DJP, Osmond C. Death rates from stroke in England and Wales predicted from past maternal mortality. BMJ. 1987;295:83-6.

  11. MINSAP. Programa nacional para la prevención, diagnóstico, evaluación y control de la hipertensión arterial. Ciudad de La Habana. 1998. 1-S8.

  12. The VI Report of the Joint National committe on prevention, detect¡on, evaluation and treatment of high blood pressure. Arch Inter Med. 1997;157:2413-46.

  13. Pérez Fernández G. Origen fetal de la enfermedad cardiovascular. La hipertension arterial como paradigma. Clínica José Ramón León Acosta, Santa Clara, Villa Clara. Cuba.

  14. CEU Universidad de San Pablo. Nutrición y Programación fetal. Antecedentes y justificación de la necesidad del programa de doctorado "Biologia molecular".

  15. Curhan GC, Willet WC, Rimm EB, Spigelman D, Ascherio AL, Stamper MJ. Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation. 1996;94:(3)246-50.

  16. Leon DA, Koupi I, Lithell HO. Failure to realise growth potential in utero and adult obesity in relation to blood pressure in 50 years old Swedish men. BMJ. 1996;312: 401-6.

  17. Moreno Villares JM, Dalmau Serra J. Alteraciones en la nutrición fetal y efectos a largo plazo, ¿algo más que una hipótesis? Acta Pediatr Esp. 2001;59(10):573-81.

  18. Ojeda NB, Grigore D, Alexander BT. Developmental programming of hypertension: insight from animal models of nutritional manipulation. Hypertension. 2008;52:44-50.

  19. Rodríguez M. Un pequeño desequilibrio temprano, un gran trastorno tardío: desequilibrio nutricional intrauterino e hipertensión arterial en el adulto. Rev Argent Cardiol. 2008 nov-dic;(6):76.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Invest Bioméd. 2014;33